TGD001 SAD study in healthy volunteers

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-514931-63-00

Enrollment

Registered

2024-11-13

Start date

2025-03-14

Completion date

2025-07-22

Last updated

2025-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

A Phase I randomized, double-blind, placebo-controlled study to assess the safety and pharmacokinetics of single-ascending doses of TGD001 in healthy volunteers

Interventions

None listed

Eligibility

Sex/Gender

Male

Age

18 Years to 64 Years

Countries

Germany

Outcome results